At one point they said the PSA blood test was useless.
Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease.
Prostate cancer is the most common cancer among men and the second-leading cause of cancer deaths, according to UC San Francisco (UCSF).
But if screening programs are introduced on a national scale — particularly those that measure levels of prostate-specific antigen (PSA) in the blood — they could give men earlier access to treatment, experts say.
They would thus have a better chance of being cured, according to reporting by news agency SWNS and others.
Screening can also prevent costly treatments associated with advanced prostate cancer.
That's according to data from the European Randomised Study of Screening for Prostate Cancer (ERSPC).
The study collects information from seven European nations — Finland, the Netherlands, Italy, Sweden, Switzerland, Belgium and Spain. It is said to be the world’s largest prostate cancer screening study, said SWNS.
Long-term data from this entity consistently shows that PSA screening programs can lead to a 20% reduced risk of dying from prostate cancer.
‘Stark contrast’
Now, an analysis of 20-year follow-up data from the ERSPC is the first to look at the link between the consistent decline of screening invitations and men's risk of dying from this type of cancer.
It reveals a "stark contrast" that emphasizes the potential consequences of screening avoidance.
Researchers from Erasmus MC Cancer Institute at the University Medical Centre in the Netherlands led the analysis, said SWNS.
Of the 72,460 men invited to partake in the screenings, around one in six were non-attenders and skipped every single appointment.
That group had a 45% higher risk of dying from prostate cancer compared with those who attended screening appointments, according to the findings.
When comparing outcomes with the control group – men who were never invited to have screenings – those who attended the screening appointments had a 23% lower risk of dying from prostate cancer, while non-attenders faced a 39% higher risk, SWNS reported.
Lead study author Renée Leenen, M.D., Ph.D., said the choice not to participate in screening may be driven by a complex collection of factors.
Said Leenen, who is with the Erasmus CM Cancer Institute in the Netherlands, "It may be that men who opted not to attend a screening appointment are care avoiders — meaning they’re less likely to engage in healthy behaviors and preventative care in general."
www.foxnews.com
Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease.
Prostate cancer is the most common cancer among men and the second-leading cause of cancer deaths, according to UC San Francisco (UCSF).
But if screening programs are introduced on a national scale — particularly those that measure levels of prostate-specific antigen (PSA) in the blood — they could give men earlier access to treatment, experts say.
They would thus have a better chance of being cured, according to reporting by news agency SWNS and others.
Screening can also prevent costly treatments associated with advanced prostate cancer.
That's according to data from the European Randomised Study of Screening for Prostate Cancer (ERSPC).
The study collects information from seven European nations — Finland, the Netherlands, Italy, Sweden, Switzerland, Belgium and Spain. It is said to be the world’s largest prostate cancer screening study, said SWNS.
Long-term data from this entity consistently shows that PSA screening programs can lead to a 20% reduced risk of dying from prostate cancer.
‘Stark contrast’
Now, an analysis of 20-year follow-up data from the ERSPC is the first to look at the link between the consistent decline of screening invitations and men's risk of dying from this type of cancer.
It reveals a "stark contrast" that emphasizes the potential consequences of screening avoidance.
Researchers from Erasmus MC Cancer Institute at the University Medical Centre in the Netherlands led the analysis, said SWNS.
Of the 72,460 men invited to partake in the screenings, around one in six were non-attenders and skipped every single appointment.
That group had a 45% higher risk of dying from prostate cancer compared with those who attended screening appointments, according to the findings.
When comparing outcomes with the control group – men who were never invited to have screenings – those who attended the screening appointments had a 23% lower risk of dying from prostate cancer, while non-attenders faced a 39% higher risk, SWNS reported.
Lead study author Renée Leenen, M.D., Ph.D., said the choice not to participate in screening may be driven by a complex collection of factors.
Said Leenen, who is with the Erasmus CM Cancer Institute in the Netherlands, "It may be that men who opted not to attend a screening appointment are care avoiders — meaning they’re less likely to engage in healthy behaviors and preventative care in general."
She added, "This is the opposite behavior of people who are perhaps more health-conscious and are more likely to attend a screening appointment … Our study identifies that men who were invited for screening, but do not attend screening appointments, are at a significantly higher risk of dying from prostate cancer compared to men who were not offered screening or accepted an invitation for screening."
Prostate cancer risk increases by 45% among men who share one troubling behavior
A new study has revealed that men who don't heed recommendations for prostate cancer screenings are at a significantly higher risk of dying from the disease.
www.foxnews.com
I use to have a female and enjoyed it, but now I have a male urologist and he rams it inside. (after almost 2 hour wait)
